159 related articles for article (PubMed ID: 18556223)
1. Discovery and development of the N-terminal procollagen type II (NPII) biomarker: a tool for measuring collagen type II synthesis.
Nemirovskiy OV; Sunyer T; Aggarwal P; Abrams M; Hellio Le Graverand MP; Mathews WR
Osteoarthritis Cartilage; 2008 Dec; 16(12):1494-500. PubMed ID: 18556223
[TBL] [Abstract][Full Text] [Related]
2. Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo.
Nemirovskiy OV; Dufield DR; Sunyer T; Aggarwal P; Welsch DJ; Mathews WR
Anal Biochem; 2007 Feb; 361(1):93-101. PubMed ID: 17187753
[TBL] [Abstract][Full Text] [Related]
3. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
4. Design and validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide in human urine: application as a biomarker of osteoarthritis.
Nemirovskiy O; Li WW; Szekely-Klepser G
Methods Mol Biol; 2010; 641():253-70. PubMed ID: 20407952
[TBL] [Abstract][Full Text] [Related]
5. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
6. Type II collagen synthesis in the articular cartilage of a rabbit model of osteoarthritis: expression of type II collagen C-propeptide and mRNA especially during early-stage osteoarthritis.
Hotta H; Yamada H; Takaishi H; Abe T; Morioka H; Kikuchi T; Fujikawa K; Toyama Y
J Orthop Sci; 2005 Nov; 10(6):595-607. PubMed ID: 16307185
[TBL] [Abstract][Full Text] [Related]
7. Type IIA procollagen: expression in developing chicken limb cartilage and human osteoarthritic articular cartilage.
Nah HD; Swoboda B; Birk DE; Kirsch T
Dev Dyn; 2001 Apr; 220(4):307-22. PubMed ID: 11307165
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.
Christensen AF; Hørslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P
J Rheumatol; 2010 Jun; 37(6):1113-20. PubMed ID: 20436079
[TBL] [Abstract][Full Text] [Related]
9. Low-intensity pulsed ultrasound (LIPUS) increases the articular cartilage type II collagen in a rat osteoarthritis model.
Naito K; Watari T; Muta T; Furuhata A; Iwase H; Igarashi M; Kurosawa H; Nagaoka I; Kaneko K
J Orthop Res; 2010 Mar; 28(3):361-9. PubMed ID: 19810106
[TBL] [Abstract][Full Text] [Related]
10. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
11. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: Use as a biomarker for aggrecanase activity and cartilage degradation.
Dufield DR; Nemirovskiy OV; Jennings MG; Tortorella MD; Malfait AM; Mathews WR
Anal Biochem; 2010 Nov; 406(2):113-23. PubMed ID: 20603097
[TBL] [Abstract][Full Text] [Related]
12. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine.
Li WW; Nemirovskiy O; Fountain S; Rodney Mathews W; Szekely-Klepser G
Anal Biochem; 2007 Oct; 369(1):41-53. PubMed ID: 17570334
[TBL] [Abstract][Full Text] [Related]
13. Evidence for altered synthesis of type II collagen in patients with osteoarthritis.
Nelson F; Dahlberg L; Laverty S; Reiner A; Pidoux I; Ionescu M; Fraser GL; Brooks E; Tanzer M; Rosenberg LC; Dieppe P; Robin Poole A
J Clin Invest; 1998 Dec; 102(12):2115-25. PubMed ID: 9854047
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine.
Swearingen CA; Carpenter JW; Siegel R; Brittain IJ; Dotzlaf J; Durham TB; Toth JL; Laska DA; Marimuthu J; Liu C; Brown DP; Carter QL; Wiley MR; Duffin KL; Mitchell PG; Thirunavukkarasu K
Osteoarthritis Cartilage; 2010 Sep; 18(9):1150-8. PubMed ID: 20633682
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis.
Rousseau JC; Zhu Y; Miossec P; Vignon E; Sandell LJ; Garnero P; Delmas PD
Osteoarthritis Cartilage; 2004 Jun; 12(6):440-7. PubMed ID: 15135140
[TBL] [Abstract][Full Text] [Related]
16. Synovial fluid concentrations of the C-propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis.
Kobayashi T; Yoshihara Y; Samura A; Yamada H; Shinmei M; Roos H; Lohmander LS
Ann Rheum Dis; 1997 Aug; 56(8):500-3. PubMed ID: 9306875
[TBL] [Abstract][Full Text] [Related]
17. [Clinical usefulness of the measurement of type-II procollagen carboxypeptide (C-II propeptide, pColl-II-C) in synovial fluid as a marker of collagen metabolism in cartilage].
Shinmei M; Nagaya I; Miyanaga Y; Iwata H; Yamamoto S; Torisu T; Fujii K; Fukubayashi T; Kondo M; Kurosaka M
Ryumachi; 1992 Oct; 32(5):453-60. PubMed ID: 1440081
[TBL] [Abstract][Full Text] [Related]
18. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.
Lohmander LS; Yoshihara Y; Roos H; Kobayashi T; Yamada H; Shinmei M
J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155
[TBL] [Abstract][Full Text] [Related]
19. A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation.
Luo Y; He Y; Reker D; Gudmann NS; Henriksen K; Simonsen O; Ladel C; Michaelis M; Mobasheri A; Karsdal M; Bay-Jensen AC
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404167
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage.
Bay-Jensen AC; Andersen TL; Charni-Ben Tabassi N; Kristensen PW; Kjaersgaard-Andersen P; Sandell L; Garnero P; Delaissé JM
Osteoarthritis Cartilage; 2008 May; 16(5):615-23. PubMed ID: 17950629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
